Navigation Links
Cellular tail length tells disease tale
Date:10/31/2013

Simon Fraser University molecular biologist Lynne Quarmby's adventures in pond scum have led her and four student researchers to discover a mutation that can make cilia, the microscopic antennae on our cells, grow too long. When the antennae aren't the right size, the signals captured by them get misinterpreted. The result can be fatal.

In a newly published paper in the science journal Current Biology, the researchers discovered that the regulatory gene CNK2 is present in cilia and controls the length of these hair-like projections.

This discovery is important because cilia, or flagella, dangle from all of our cells. Their ability to propel some cells, such as sperm, and allow molecular communication in others, for example cellular responses to hormones, determines how we develop from embryos and how our bodies function in adulthood.

When cilia are too short or too long they cause various human hereditary diseases and deformities, such as too many fingers or toes, blindness and Polycystic Kidney Disease, which affects one in 600 people.

Quarmby and her doctoral student Laura Hiltonsenior and lead authors, respectively, on this paperare among the few scientists globally who study cilia-disassembly as opposed to -assembly.

A crucial part of all cells' lifecycle is their cilia's disassembly before cell division and assembly after it. The gene LF4 is a known assembly regulator, and, prior to this study, scientists thought that assembly speed controlled cilia's ultimate length or shrinkage. But Quarmby and Hilton have discovered that disassembly speed is also important, and that the regulatory gene CNK2 plays a key role in controlling it.

Similar to how a balance between water pressure and gravity determines the height of a fountain's stream, a balance of assembly and disassembly speed determines cilia's length. When growing and shrinking happen simultaneously cilia length remains constant.

Pond scum's algae make good lab models for analyzing this because they reproduce quickly, and they have cellular structure and cilia that closely parallel ours. Quarmby and Hilton have been mucking about with pond scum for years and recently started studying algae cilia with defective CNK2 and LF4 genes.

After discovering that cilia with either defective gene are abnormally long, they created an algae cell with four cilia, instead of the normal two, with two of the four engineered to glow green.

Along with two SFU undergrad students and a University of Toronto undergrad, Quarmby and Hilton watched as the fluorescent green tag began to appear at the tip of the untagged pair of cilia.

"We were able to deduce how the mutations affected the cilia's assembly and disassembly by measuring how much and how quickly green fluorescence appeared at the tip of the untagged cilia," explains Quarmby.

"We knew that we had something important when we saw that cells bearing mutations in both CNK2 and LF4 had the most extraordinarily long cilia. They were unlike anything anyone had ever seen before.

"My student Laura ran this experiment and oversaw our undergrad researchers. It gave us unique insights into the potentially key role disassembling cilia have in deciding the tails' length. Further investigation will help us understand how ciliary malfunction causes a progression of diseases."

The SFU undergrads working with Quarmby and Hilton were Kavisha Gunawardane and Marianne Schwarz. The UofT student was Joo Wan (James) Kim.


'/>"/>

Contact: Carol Thorbes
cthorbes@sfu.ca
778-782-3035
Simon Fraser University
Source:Eurekalert

Related medicine news :

1. Cellular pathway linked to diabetes, heart disease
2. Why omega-3 oils help at the cellular level
3. Discovery explains how cellular pathways converge to regulate food intake and body weight
4. New technique reveals cross-talk between 2 essential cellular processes
5. LA BioMed investigator, Dr. Yutaka Niihara, developing novel cellular therapy
6. Molecular switch identified that controls key cellular process
7. MedScope Announces Changes to the Medical Alarm Industry, Bringing it into the Cellular Age
8. The new age of proteomics: An integrative vision of the cellular world
9. Research explores road signs on the intracellular highway
10. Extracellular vesicles may open new opportunities for brain cancer diagnosis and treatment
11. Study: HIV Infection Does Not Adversely Affect Outcomes of Liver Transplantation for Hepatocellular Carcinoma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/12/2017)... ... ... IsoComforter, Inc. ( https://isocomforter.com ), one of the Nation’s premier ... of the shoulder pad. The shoulder pad provides optimal support and full contact ... using cold therapy. By utilizing ice and water that is circulated from an insulated ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
(Date:10/12/2017)... Washington, D.C. (PRWEB) , ... October 12, 2017 , ... ... of their peers in Washington, D.C., for the 49th Congress of the International ... Ph.D ., Vice President of the Center for Cancer and Blood Disorders ...
(Date:10/12/2017)... ... October 12, 2017 , ... Health Literacy Innovations (HLI), ... software tool, and the Cancer Patient Education Network (CPEN), an independent professional organization ... a new strategic alliance. , As CPEN’s strategic partner, HLI will help ...
(Date:10/12/2017)... , ... October 12, 2017 , ... ... at the University of California Berkeley, and other leading institutions in announcing the ... power of institutions to change the way animals are raised for food. , ...
Breaking Medicine News(10 mins):
(Date:9/28/2017)... 28, 2017 Cohen Veterans Bioscience and Early ... of wearable and home sensors for real-time monitoring of ... Foundation, a nonprofit organization focused on disruptive health solutions ... affordable analytical system to record and integrate behavioral, cognitive, ... ...
(Date:9/25/2017)... 25, 2017  EpiVax, Inc., a leader in ... immune-engineering today announced the launch of EpiVax Oncology ... personalized therapeutic cancer vaccines. EpiVax has provided $500,000 ... to enabling technologies to the new precision immunotherapy ... EpiVax Oncology as Chief Executive Officer. Gad brings ...
(Date:9/19/2017)... Mich. , Sept. 19, 2017 HistoSonics, Inc., a venture-backed medical device company ... destruction of targeted tissues, announced three leadership team developments today:   ... PhD ... ... Veteran medical device executive Josh ...
Breaking Medicine Technology: